Home/Future Journal of Pharmaceutical Sciences/Article Record
Peer-Reviewed Article March 2, 2016

Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Future Journal of Pharmaceutical Sciences
Publisher: Springer Science+Business Media • Egypt • 2314-7245
DOI: https://doi.org/10.1016/j.fjps.2016.02.001

Abstract

Quinazoline derivatives are fused heterocyclic ring systems which have been explored for their inhibitory activity towards various protein kinase enzymes and their role as anticancer agents. The present review to represent the most recent synthetic strategies and medicinal aspects including structure activity relationships of substituted quinazolines as EGFR inhibitors reported to date.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

83
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.